Community Healthcare Trust Incorporated (CHCT) P/E Ratio History
ExpensiveTrading at 184.4x vs 5Y avg 78.4x · 95th percentile · Material premium to history · Data 2016–2026
Loading P/E history...
P/E Ratio Analysis
As of September 24, 2026, Community Healthcare Trust Incorporated (CHCT) trades at a price-to-earnings ratio of 184.4x, with a stock price of $14.27 and trailing twelve-month earnings per share of $0.78.
The current P/E is 135% above its 5-year average of 78.4x. Over the past five years, CHCT's P/E has ranged from a low of 27.2x to a high of 221.3x, placing the current valuation at the 95th percentile of its historical range.
Compared to the Real Estate sector median P/E of 22.2x, CHCT trades at a 730% premium to its sector peers. The sector includes 175 companies with P/E ratios ranging from 0.0x to 184.4x.
Relative to the broader market, CHCT commands a significant premium over the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CHCT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CHCT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CHCT P/E vs Peers
Outpatient medical offices and clinics peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $94M | 115.3 | - | -394% | |
| $2B | 224.0 | 3.78 | +151%Best | |
| $14B | 23.8 | 1.02Best | +25% | |
| $5B | 30.8 | - | +19% | |
| $2B | 16.9Lowest | - | +24% | |
| $9B | 23.7 | 1.12 | +96% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CHCT Historical P/E Data (2016–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $18.28 | $0.67 | 27.2x | -75% |
| FY2026 Q1 | - | $15.89 | $0.11 | 140.6x | +29% |
| FY2025 Q4 | Dec 31 2025 | $16.42 | $0.07 | 221.3x | +103% |
| FY2024 Q1 | Mar 31 2024 | $26.55 | $0.61 | 43.5x | -60% |
| FY2023 Q4 | Dec 31 2023 | $26.64 | $0.18 | 148.0x | +36% |
| FY2023 Q3 | Sep 30 2023 | $29.70 | $0.22 | 135.0x | +24% |
| FY2023 Q2 | Jun 30 2023 | $33.02 | $0.35 | 94.3x | -14% |
| FY2023 Q1 | Mar 31 2023 | $36.60 | $0.35 | 104.6x | -4% |
| FY2022 Q4 | Dec 31 2022 | $35.80 | $0.90 | 39.8x | -64% |
| FY2022 Q3 | Sep 30 2022 | $32.75 | $0.94 | 34.8x | -68% |
| FY2022 Q2 | - | $36.21 | $0.90 | 40.2x | -63% |
| FY2022 Q1 | - | $42.21 | $0.88 | 48.0x | -56% |
| FY2021 Q4 | Dec 31 2021 | $47.27 | $0.86 | 55.0x | -50% |
| FY2021 Q3 | - | $45.19 | $0.87 | 51.9x | -52% |
| FY2021 Q2 | Jun 30 2021 | $47.46 | $0.89 | 53.3x | -51% |
| FY2021 Q1 | Mar 31 2021 | $46.12 | $0.86 | 53.6x | -51% |
| FY2020 Q4 | - | $47.11 | $0.83 | 56.8x | -48% |
| FY2020 Q3 | Sep 30 2020 | $46.76 | $0.68 | 68.8x | -37% |
| FY2020 Q2 | - | $40.90 | $0.58 | 70.5x | -35% |
| FY2020 Q1 | - | $38.28 | $0.48 | 79.8x | -27% |
| FY2019 Q4 | - | $42.86 | $0.36 | 119.1x | +9% |
| FY2019 Q3 | Sep 30 2019 | $44.55 | $0.16 | 278.4x | +155% |
| FY2019 Q2 | Jun 30 2019 | $39.41 | $0.14 | 281.5x | +158% |
| FY2019 Q1 | Mar 31 2019 | $35.89 | $0.17 | 211.1x | +94% |
| FY2018 Q4 | Dec 31 2018 | $28.83 | $0.20 | 144.2x | +32% |
| FY2018 Q3 | Sep 30 2018 | $30.98 | $0.41 | 75.6x | -31% |
| FY2018 Q2 | Jun 30 2018 | $29.87 | $0.33 | 90.5x | -17% |
| FY2018 Q1 | Mar 31 2018 | $25.74 | $0.25 | 103.0x | -6% |
| FY2017 Q4 | Dec 31 2017 | $28.10 | $0.23 | 122.2x | +12% |
| FY2017 Q3 | Sep 30 2017 | $26.96 | $0.21 | 128.4x | +18% |
| FY2017 Q2 | Jun 30 2017 | $25.59 | $0.27 | 94.8x | -13% |
| FY2017 Q1 | Mar 31 2017 | $23.90 | $0.27 | 88.5x | -19% |
| FY2016 Q4 | Dec 31 2016 | $23.03 | $0.22 | 104.7x | -4% |
| FY2016 Q3 | Sep 30 2016 | $21.92 | $0.17 | 132.5x | +21% |
| FY2016 Q2 | - | $21.14 | $0.08 | 276.3x | +153% |
Average P/E for displayed period: 109.1x
CHCT Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CHCT — Frequently Asked Questions
Quick answers to the most common questions about buying CHCT stock.
What is CHCT's P/E ratio?
Community Healthcare Trust Incorporated (CHCT) trailing twelve-month P/E ratio is 184.4x, based on TTM diluted EPS of $0.78. The 5-year average P/E is 78.4x and the historical range spans 27.2x to 221.3x.
Is CHCT stock overvalued or undervalued?
CHCT trades at 184.4x P/E, above its 5-year average of 78.4x. The 95th percentile ranking within the 27.2x–221.3x historical range indicates a premium to historical valuation.
Is CHCT stock expensive?
Yes, CHCT is expensive relative to its own history. The current P/E of 184.4x is above the 5-year average of 78.4x and also above the Real Estate sector median of 22.2x. The stock sits at the 95th percentile of its 5-year valuation range.
What is CHCT's historical P/E range?
Over the past 5 years, CHCT's P/E ratio has ranged from 27.2x to 221.3x, with a median of 56.8x and an average of 78.4x. The current P/E of 184.4x places the stock at the 95th percentile of this range. Full historical data spans 2016–2026.
How does CHCT's P/E compare to the S&P 500?
CHCT trades at 184.4x P/E versus the S&P 500 median of 25.3x. The 629% premium to the market typically reflects higher expected earnings growth or quality.
How does CHCT's valuation compare to Real Estate peers?
Community Healthcare Trust Incorporated P/E of 184.4x compares to the Real Estate sector median of 22.2x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CHCT's PEG ratio?
CHCT PEG ratio is N/A, based on a P/E of 184.4x and EPS growth of 133.7%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CHCT's earnings yield?
CHCT earnings yield is 0.54%, the inverse of its 184.4x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.